From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. HIV/AIDS Clinical Care>
  4. Antiretroviral Rounds

HIV/AIDS Clinical Care: Antiretroviral Rounds

Some content may require paid access to the site. Subscribe or purchase a seven-day site pass for the full text of all our clinical perspectives on medical journal articles, guidelines, and news.


to
Items 1-10 of 57 are shown

Stuck in the Middle

A clinician sustains a needlestick from a patient who refuses HIV testing. An HIV physician, an attorney, and an ethicist weigh provide weigh in on how best to manage.

Should We Mess with Success?

Experts grapple with whether to change the regimens for three patients who had undetectable viral loads and normal or near-normal CD4-cell counts and were tolerating their treatments well.

Should We Mess with Success?

Should the regimens be changed for three patients who have undetectable viral loads and normal or near-normal CD4-cell counts and are tolerating their treatments well?

When Your Patient Is Too Busy to Take Meds

Two experts describe how they would encourage adherence in an AIDS patient already overburdened with work and family responsibilities.

Happy 50th? Sedation for Colonoscopy in HIV-Infected Patients

We asked three experts — two pharmacologists and a gastroenterologist — about their approaches to sedation in HIV-infected patients receiving ritonavir.

Too Many Options?

We asked three experts which antiretroviral regimen they would recommend next for a patient with triple-class resistance and low-level viremia — and got three different answers.

PEP During Early Pregnancy?

Two experts discuss the pros and cons of recommending postexposure prophylactic antiretroviral therapy to a healthcare provider who was exposed to HIV during her first trimester of pregnancy.

Immediate ART After an OI: Are We There Yet?

Experts explain how they would approach ART initiation in a newly diagnosed patient with cryptococcal meningitis.

Is That "One Pill" Treatment Enough?

Two experts describe how they would manage a patient with isolated resistance to 3TC/FTC who has requested the "one-pill" HIV treatment.

Resistance: What You Don’t Know — Can It Hurt You?

Two experts weigh in on whether to switch regimens in a patient with evidence of triple-class resistance.

Items 1-10 of 57 are shown

to

Search

Advanced

Sign-In

Forgot your password?

New to Journal Watch?





Copyright © 2009. Massachusetts Medical Society. All rights reserved.